Hand and Globe

END TO END
REGULATORY AFFAIRS AND
COMPLIANCE SERVICES

We provide Regulatory Affairs, Clinical, Quality Audits, and Pharmacovigilance Services across the entire life cycle.

Industries

INDUSTRIES WE SERVE
Pharmaceuticals, Medical Devices, Cosmetics, Nutraceuticals, and Food Supplements.

Globe

GLOBAL REACH, LOCAL PRESENCE AND EXPERTISE
Local offices in USA, Asia, Latin America, and Europe.

previous arrowprevious arrow
next arrownext arrow

About Global Regulatory Partners Group

The GRP-Group offers end-to-end Regulatory Affairs, Clinical, Quality, Pharmacovigilance solutions to Medtech,  Pharmaceuticals, Biotech, Cosmetics and life-consumer companies to help them access new market in record time and minimum investment, while ensuring Compliance with local regulations. 

GRP Local Offices

GRP Achievements

Clients
1 +
Projects
1 +
Offices World Wide
1

Customer Testimonial

From our Blog

Anvisa
ANVISA

ANVISA explains how drug safety is assessed in the pharmacovigilance cycle

Pharmacovigilance is essential to ensure that medicines marketed in Brazil continue to be safe and effective over time. Even after approval and market entry, these products continue to be monitored through a structured cycle that involves detecting adverse events, analyzing risks and adopting corrective measures. In this blog, you will understand how this process coordinated by ANVISA works, what the roles of each agent involved are and why the participation of society is so important.

Read More »

COFEPRIS: Self-Verification Guide for Warehouses Storing and Distributing Medicines and Other Health Supplies

Mexico’s health regulatory authority, COFEPRIS, has published a Self-Verification Guide designed for companies operating warehouses that store and distribute medicines and other health-related supplies. This initiative aims to strengthen compliance with sanitary regulations, standardize procedures, and help businesses identify nonconformities—ultimately improving safety and traceability across the supply chain.

Read More »
Brazil Anvisa
ANVISA

ANVISA Opens Public Consultation on New Regulatory Framework for Medical Devices in Brazil

Brazil’s national health surveillance agency, ANVISA, has launched a targeted public consultation as part of its effort to revise and modernize the regulatory framework for medical devices. This initiative aims to align Brazilian regulations with international best practices, enhance patient safety, and foster innovation. Stakeholders across the health and regulatory sectors are invited to submit their contributions and insights.

Read More »